Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Liabilities and Shareholders Equity (2016 - 2022)

Sonoma Pharmaceuticals (SNOA) has 2 years of Liabilities and Shareholders Equity data on record, last reported at $11.8 million in Q4 2012.

  • For Q4 2012, Liabilities and Shareholders Equity rose 31.72% year-over-year to $11.8 million; the TTM value through Mar 2013 reached $34.9 million, up 3.32%, while the annual FY2012 figure was $7.8 million, 9.53% down from the prior year.
  • Liabilities and Shareholders Equity reached $11.8 million in Q4 2012 per SNOA's latest filing, down from $13.4 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $13.4 million in Q3 2012 and bottomed at $7.8 million in Q3 2011.